Effective Treatment with Eleftha 150mg Injection

Uses:

• Advanced and metastatic breast cancer;
• Metastatic gastric cancer with increased levels of HER2 proteins.

Mechanism of action:

• Contains Trastuzumab as an active constituent;
• Selectively binds to HER2 proteins, stopping the growth of cancer cells.

Important information:

• Not recommended for patients under 18, those with severe breathing problems, or those needing oxygen treatment;
• Inform your physician about all medications, including supplements and herbal medicines, before starting treatment;
• Keep out of reach of children;
• Store between 2˚C and 8˚C.

Administration:

• Administered intravenously;
• Infusion lasts 90 minutes, then administered within 30 minutes for subsequent doses if well tolerated.

Safety advice:

• Pregnancy: discuss with your physician before taking;
• Breastfeeding: avoid breastfeeding while on treatment and for at least seven months after the final dose;
• Lungs: consult your doctor if you have any lung conditions;
• Liver: inform your physician of any liver disorders;
• Alcohol: consult your doctor about alcohol consumption during treatment;
• Driving: avoid driving or handling machinery due to potential side effects like dizziness and tiredness.

Side effects:

• Serious: heart problems, allergic reactions, kidney problems, breathing difficulties;
• Common: fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, asthma/lung disorders.

FAQs:

• Q1. Is Eleftha 150mg Injection used as a monotherapy in treating breast cancer?
  • Eleftha 150mg Injection is generally given along with chemotherapy medications such as paclitaxel or docetaxel or platinum compounds. Sometimes it is also given with hormonal agents.
• Q2. Does Eleftha 150mg Injection cause heart problems?
  • Yes, Eleftha 150mg Injection can damage the heart muscles. Regular heart check-ups are advised.
• Q3. Can I breastfeed while on treatment with Eleftha 150mg Injection?
  • No, it is unsafe to breastfeed while on treatment. Avoid breastfeeding for at least 7 months after the last dose.
• Q4. Can Eleftha 150mg Injection be consumed during pregnancy?
  • No, it is unsafe to consume Eleftha 150mg Injection during pregnancy. It can harm the baby and affect fetal development.

Fact box:

• Molecule name: Trastuzumab;
• Therapeutic class: Anti-cancer;
• Pharmacological class: HER2 inhibitor.

Теги: medical-injection, eleftha-drug, pharmaceuticals, 150mg-dose